renal colic. unspecified renal colic
Conditions
Interventions
Intervention 1: Intervention group: Patients with renal colic that receive 10 mg intramuscular Morphine Sulfate (manufactured by Darou Pakhsh Pharmaceutical Co.) for control of pain. Intervention 2: C
Treatment - Drugs
Intervention group: Patients with renal colic that receive 10 mg intramuscular Morphine Sulfate (manufactured by Darou Pakhsh Pharmaceutical Co.) for control of pain
Control group: Patients with renal colic that receive 10 mg suppository of Morphine Sulfate (brand name: Opirect, manufactured by Aburaihan Pharmaceutical Co.) for control of pain
Sponsors
Vice Chancellor for research of Semnan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 18-55 years old patients with unilateral acute flank or abdominal colicky pain that in evaluation of the patient with ultrasonography, CT scan or intravenous pyelography presence of the urinary stone is approved or the patient passes the stone. Exclusion criteria : sensitivity to morphine; addiction; fever higher than 38 degrees of centigrade; unstable hemodynamic condition; impaired hepatic or renal function; heart failure; respiratory failure; suspected to peritonitis; pregnancy or suspected to pregnancy; transplanted kidney; suspected to aneurysm or dissection of aorta and receiving analgesic within 6 hours before admission.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: Before intervention, 15, 30 and 60 minutes after intervention. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Before intervention, 15, 30 and 60 minutes after intervention. Method of measurement: Sphygmomanometer.;Heart rate. Timepoint: Before intervention, 15, 30 and 60 minutes after intervention. Method of measurement: Counting the number of radial pulse.;Respiratory rate. Timepoint: Before intervention, 15, 30 and 60 minutes after intervention. Method of measurement: Counting the number of breaths.;Nausea and Vomiting. Timepoint: Before intervention, 15, 30 and 60 minutes after intervention. Method of measurement: Question of the patient and observation.;Dizziness. Timepoint: 15, 30 and 60 minutes after intervention. Method of measurement: Question of the patient.;Drowsiness. Timepoint: 15, 30 and 60 minutes after intervention. Method of measurement: Observation.;Facial Flushing. Timepoint: 15, 30 and 60 minutes after intervention. Method of measurement: Observation.;Size of urinary stone. Timepoint: After intervention. Method of measurement: Imaging findings.;Location of the stone. Timepoint: After intervention. Method of measurement: Imaging findings. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Arash Ardestani Zadeh
Semnan University of Medical Sciences
Outcome results
None listed